Relative Bioavailability of a Single Dose of 150 mg Dabigatran Etexilate (Capsule) When Administered Alone or in Combination With a Single Dose of 400 mg Dronedarone Tablet) or in Combination With 400 mg Bid Dronedarone (Tablet) at Steady State in Healthy Male and Female Volunteers (an Open Label, Randomised, Four-sequence, Two Period Cross-over, Phase I Study).
Phase of Trial: Phase I
Latest Information Update: 10 Dec 2013
At a glance
- Drugs Dabigatran etexilate (Primary) ; Dronedarone
- Indications Arrhythmias; Venous thromboembolism
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim Pharmaceuticals
- 28 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 11 Mar 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 08 Mar 2011 New trial record